Thymalfasin (Thymosin Alpha 1; Ta1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Thymalfasin (Thymosin Alpha 1; Ta1), covering 2025-07-31 to 2025-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine [Phase 1]